IPO registrations (S-1, F-1) · Registrants
PROTALEX INC
- SEC CIK
- 1099215 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2014-02-20, last 2016-06-03; 2 initial registrations, 1 amendment
- Outcome
- Withdrawal requested 2014-11-25
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 131 COLUMBIA TURNPIKE, SUITE 1, Florham Park, NJ 07932
- EIN
- 91-2003490
- EDGAR entity type
- operating
- Insiders and CEO pay
- PROTALEX INC on the corporate pages
Offering terms
- Listing
- Nasdaq under the symbol PRTX
- Lead underwriters
- Chardan
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Federal award recipient: PROTALEX, INC. Fuzzy (name and state)
- Form D issuer: PROTALEX INC EXACT (CIK (EXACT))
- SEC filer: PROTALEX INC EXACT (CIK (EXACT))
Filings 4
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-02-20 | S-1 | S-1 (registration) | PROTALEX INC | 0001144204-14-010762 ↗ |
| 2014-11-25 | RW | RW (withdrawal request) | PROTALEX INC | 0001144204-14-070815 ↗ |
| 2015-07-31 | S-1 | S-1 (registration) | PROTALEX INC | 0001144204-15-045512 ↗ |
| 2016-06-03 | S-1/A | S-1/A (amendment) | PROTALEX INC | 0001144204-16-106760 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2016-06-03 | S-1/A | registration statement | $4.30 | - | - | Nasdaq PRTX | 1 | primary document; price line, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| DOHERTY JOHN E | Director; TenPercentOwner | 5 | 2006–2012 | ||
| DOUGHERTY FRANK M | Director | 5 | 2006–2009 | ||
| TOMBROS PETER G | Director | 5 | 2006–2009 | ||
| Rose Marc L | Officer | See Remarks; VP of Finance, CFO & Treasurer; VP of Finance, CFO, Treasurer; VP of Finance,CFO,Treasurer&CS; VP of Fin., CFO, see remarks | 5 | 2006–2008 | |
| Sloan Victor S | Officer | SVP & Chief Medical Officer | 2 | 2006 | |
| STAGNARO THOMAS PETER | Director | 5 | 2006–2009 | ||
| BAUER EUGENE A | Director | 4 | 2006–2009 | ||
| HOLSTROM CARLETON A | Director; Director,Officer | President and CEO | 7 | 2006–2009 | |
| KANE STEVEN H | Director,Officer | President; President and CEO; President & CEO | 4 | 2006–2008 | |
| RAAB G KIRK | Director | 4 | 2006–2009 | ||
| PATEL DINESH C | Director,TenPercentOwner | 1 | 2008 | ||
| VSPRING SBIC LP | TenPercentOwner | 1 | 2008 | ||
| KLING ARNOLD P | Director,Officer,TenPercentOwner; Director,TenPercentOwner | President | 7 | 2009–2018 | |
| NIOBE VENTURES, LLC | TenPercentOwner | 4 | 2009–2018 | ||
| WARSHAW KIRK M | Officer | Chief Financial Officer | 7 | 2009–2018 | |
| ELSER MARCO M | Director | 5 | 2014–2018 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2018-03-09 | PROTALEX INC | Biotechnology | $2,000,000 | $1,425,000 | 8 | 1 |
| 2014-01-23 | PROTALEX INC | Other | $2,828,000 | $2,828,000 | 23 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Federal award recipient | PROTALEX, INC. | NJ | Federal spending (USAspending) | name and state |
| Form D issuer | PROTALEX INC | NJ | Form D private offerings | CIK (EXACT) |
| Patent assignee | Protalex, Inc. | NJ | Patents (USPTO) | name and state |
| SEC filer | PROTALEX INC | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, NJ first:
- QUEST DIAGNOSTICS INVESTMENTS INC NJ
- PharmaNet Development Group Inc NJ
- LIFE SCIENCES RESEARCH INC NJ
- Redpoint Bio CORP NJ
- WCG Clinical, Inc. NJ
- SENTIGEN HOLDING CORP NJ
- WEED, INC. AZ
- GLYCOTEX, INC. C3
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
In other datasets, the same topic (Medical research) in NJ:
- Form D issuer: Aadi Bioscience, Inc. (Form D private offerings)
- Nonprofit: ACNE CURE ALLIANCE INC (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research